Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma

por Demosthenous, Christos, Han, Jing Jing, Hu, Guangzhen, Stenson, Mary, Gupta, Mamta
Publicado 2015

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

por Abeykoon, Jithma P., Paludo, Jonas, Nowakowski, Kevin E., Stenson, Mary J., King, Rebecca L., Wellik, Linda E., Wu, Xiaosheng, Witzig, Thomas E.
Publicado 2019

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

por Demosthenous, Christos, Han, Jing Jing, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Link, Brian, Hege, Kristen, Dogan, Ahmet, Sotomayor, Eduardo, Witzig, Thomas, Gupta, Mamta
Publicado 2015

Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma

por Han, Jing Jing, O’byrne, Megan, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Feldman, Andrew L., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta
Publicado 2018